Literature DB >> 15879152

Activation of discoidin domain receptor 1 on CD14-positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis.

Wataru Matsuyama1, Masaki Watanabe, Yuko Shirahama, Ken-Ichi Oonakahara, Ikkou Higashimoto, Teizo Yoshimura, Mitsuhiro Osame, Kimiyoshi Arimura.   

Abstract

Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase activated by collagen. We previously reported the functional expression of DDR1 on human monocyte-derived macrophages in vitro; however, information regarding its role in diseases is limited. Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease, and the lesions contain an abundance of collagen. In this study, we examined DDR1 expression on bronchoalveolar lavage fluid (BALF) cells and investigated its functionality using samples obtained from 28 IPF patients, 13 chronic obstructive pulmonary disease patients, and 14 healthy volunteers. The DDR1 expression level in CD14-positive BALF cells was higher in IPF patients than in chronic obstructive pulmonary disease patients or healthy volunteers. The predominant isoform was DDR1b in the IPF group, while DDR1a was predominant in the other two groups. Using immunohistochemical analysis, we also detected DDR1 expression on infiltrating inflammatory cells in the IPF lesion. In IPF patients, DDR1 activation induced the production of MCP-1, IL-8, MIP-1 alpha, and matrix metalloproteinase-9 (MMP-9) from CD14-positive BALF cells in a p38 MAPK-dependent manner. In contrast, DDR1 activation of CD14-positive BALF cells in the other groups did not induce the production of these chemokines or MMP-9. These chemokines and MMP-9 contribute to the development of IPF and, therefore, we suggest that DDR1 might be associated with the pathogenesis of IPF in the tissue microenvironment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15879152     DOI: 10.4049/jimmunol.174.10.6490

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Mesenchymal Stem Cells Sense Three Dimensional Type I Collagen through Discoidin Domain Receptor 1.

Authors:  A W Lund; J P Stegemann; G E Plopper
Journal:  Open Stem Cell J       Date:  2009

2.  Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis.

Authors:  Wataru Matsuyama; Masaki Watanabe; Yuko Shirahama; Hideo Mitsuyama; Ikkou Higashimoto; Mitsuhiro Osame; Kimiyoshi Arimura
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Age-dependent expression of collagen receptors and deformation of type I collagen substrates by rat cardiac fibroblasts.

Authors:  Christopher G Wilson; John W Stone; Vennece Fowlkes; Mary O Morales; Catherine J Murphy; Sarah C Baxter; Edie C Goldsmith
Journal:  Microsc Microanal       Date:  2011-07-11       Impact factor: 4.127

4.  Increased serum high mobility group box-1 level in Churg-Strauss syndrome.

Authors:  T Taira; W Matsuyama; H Mitsuyama; K-I Kawahara; I Higashimoto; I Maruyama; M Osame; K Arimura
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

5.  Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1.

Authors:  Daizo Yoshida; Akira Teramoto
Journal:  J Neurooncol       Date:  2006-09-26       Impact factor: 4.130

6.  Serum N-terminal DDR1: A Novel Diagnostic Marker of Liver Fibrosis Severity.

Authors:  Yuxin Zhang; Yujie Zhang; Huifang Liang; Zeng Zhuo; Pan Fan; Yifa Chen; Zhanguo Zhang; Wanguang Zhang
Journal:  J Clin Transl Hepatol       Date:  2021-04-25

7.  Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.

Authors:  Silvia Avino; Paola De Marco; Francesca Cirillo; Maria Francesca Santolla; Ernestina Marianna De Francesco; Maria Grazia Perri; Damiano Rigiracciolo; Vincenza Dolce; Antonino Belfiore; Marcello Maggiolini; Rosamaria Lappano; Adele Vivacqua
Journal:  Oncotarget       Date:  2016-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.